Glenmark Life Sciences (GLS.NSE) Q2 2025 Earnings

May 15Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
7.63
8.95
10.27
11.6

Details

Expected EPS
10.19873744196
Actual EPS
11.598564149680001
Surprise EPS
1.4
Surprise Percent
+13.73%

Description

⁨Glenmark Life Sciences⁩ (⁦GLS.NSE⁩) has reported earnings of ⁦11.598564149680001⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts